MAXIM GROUP
Maxim Group is a leading investment banking, securities and investment management firm. The Firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products, and global institutional equity, fixed-income and derivative sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is registered as a broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); International Securities Exchange (ISE); NASDAQ Stock Market; and NYSE Arca, Inc.
MAXIM GROUP
Industry:
Financial Services FinTech Venture Capital Wealth Management
Founded:
2002-01-01
Status:
Active
Contact:
800-537-6923
Email Addresses:
[email protected]
Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Hosting Cloudflare DNS DMARC
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-15 | Nacuity Pharmaceuticals | Maxim Group investment in Series B - Nacuity Pharmaceuticals | 16.5 M USD |
| 2018-01-05 | Alveo Technologies | Maxim Group investment in Series A - Alveo Technologies | 38 M USD |
| 2017-10-19 | Abeona Therapeutics | Maxim Group investment in Post-IPO Equity - Abeona Therapeutics | 92 M USD |
| 2013-06-04 | Edge Therapeutics | Maxim Group investment in Series C - Edge Therapeutics | 18 M USD |
| 2011-09-15 | ContraFect | Maxim Group investment in Venture Round - ContraFect | 12.5 M USD |
| 2010-11-24 | BillMyParents | Maxim Group investment in Venture Round - BillMyParents | 3.4 M USD |
Newest Events participated
Participated in Impact Investor Conference
on 2015-06-19 as sponsor